Sampling and follow-up sheeme

Sampling

The sampling method used was density sampling. This plot shown a time scheme of the recruitment of cases with an example of 5 pairs of cases. Incident Diabetes cases were selected as they occurred and their respective controls of the same sex, age on inclusion date.

A case is a person who is recorded as diabetes at index date. A control is a person who has not yet have diabetes at the index date of the case. The index date of the case can also be the onset of a disease (Diabetes), in which case controls are persons who do not yet have the disease (are not yet exposed).

Follow-up

Once identified, they are followed until the end of follow-up. Which determines your time at risk (Black line). The follow-up was until 12/31/2018, until death or until switch group

Switch group

Example of change of group


Flow-Chart

Flow-Chart

Flow chart of how the sample finally analyzed has been arrived at. Initially we started from a potential population from Barcelona of 85,919, of which 10,065 Diabetics (Prevalent as incidents) + 75,854 potential controls. Of these, 8004 diabetics and 8004 controls of the same age and sex were matched.

Incidence

Incidence rates

During the follow-up, we collected data on Tuberculosis event recorded.

Number of subjects, tuberculosis events, and incidence rate (per 100.000 persons-year) and confidence interval (95%CI), Overall, by groups and type of diabetes during the follow-up

Group Subjects (N) Persons-years Tuberculosis events Incidence rate (95% CI)
Overall 16008 129804 73 56.2 (44.1;70.7)
Control 8004 61198 25 40.9 (26.4;60.3)
Diabetes 8004 68605 48 70.0 (51.6;92.8)
DM1 355 3505 2 57.1 (6.9;206.1)
DM2 7649 65101 46 70.7 (51.7;94.3)
DM Incident 3641 22965 23 100.2 (63.5;150.3)
DM Prevalent 4363 45640 25 54.8 (35.4;80.9)

Cumulative incidence curve by group

Sensitivity analysis

Sensitivity analysis

Additional analyses in order to check the robustness of the results include the different approach models

Model specifications
Model Adjust variables
1 Origin
2 Origin, Visits
3 Origin, CKD, BMI, Visits
4 Origin, Alcholism, Smoke, CKD, BMI, Visits
Methods

Competing risk: Competing Risks Regression for Clustered Data. Regression modeling of subdistribution hazards for clustered right censored data. Failure times within the same cluster are dependent. crrs R package Vesion 1.1. This method extends Fine-Gray proportional hazards model for subdistribution (1999) to accommodate situations where the failure times within a cluster might be correlated since the study subjects from the same cluster share common factors This model directly assesses the effect of covariates on the subdistribution of a particular type of failure in a competing risks setting.

Bingqing Zhou and Aurelien Latouche (2013). crrSC: Competing risks regression for Stratified and Clustered data. R package version 1.1. https://CRAN.R-project.org/package=crrSC

Cox PH by clusters: Fits a Cox proportional hazards regression model with clusters. coxph function from {survival} R packages Therneau T (2015). A Package for Survival Analysis in S. version 2.38, <URL: https://CRAN.R-project.org/package=survival>.

Full model

Full model

About

Authors and affiliations

Authors: Antonio-Arques, Violeta (VA)1,2 ; Franch-Nadal, Josep1,3,4; Moreno-Martinez, Antonio (AM)5,6; Real Gatius, Jordi(JR)1,4; Orcau, Àngels(AO)6,7; Mauricio, Dídac (DM)1,4,8,9; Mata-Cases, Manel (MM)1,4,10; Julve, Josep (JJ)4,11; Navas Mendez, Elena (EN) 12; Puig Treserra, Rai (RP)1; Barrot de la Puente, Joan (JB)1,13; Millet, Joan-Pau (JP)6,7; Del Val García, Jose Luís (JLV)12,14; Vlacho, Bogdan (BV)^1; Caylà, Joan A (JC)15

Affiliations

  1. DAP-Cat group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain
  2. Primary Health Care Center Bordeta Magòria, Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut, 08014 Barcelona, Spain
  3. Primary Health Care Center Raval Sud, Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut, 08028 Barcelona, Spain
  4. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain
  5. Department of Infectious Diseases, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
  6. CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
  7. Epidemiology Service, Agència de Salut Pública de Barcelona, 08023 Barcelona, Spain
  8. Department of Endocrinology and Nutrition, Hospital Universitari de la Santa Creu i Sant Pau, 08041 Barcelona, Spain
  9. Department of Medicine, University of Vic - Central University of Catalonia, 08500 Vic, Spain
  10. Primary Health Care Center La Mina, Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut, 08930 Barcelona, Spain
  11. Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain
  12. Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.
  13. Primary Health Care Center Doctor Jordi Nadal, Gerència d’Atenció Primària Girona Ciutat, Institut Catala de la Salut, 17190 Salt, Spain.
  14. Unitat d’Avaluació, Sistemes d’informació i Qualitat, Gerència d’Àmbit d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut, 08029 Barcelona, Spain
  15. Foundation of the Tuberculosis Research Unit of Barcelona, Barcelona, Spain

Correspondence: ;

Author Contributions: VA, JC, JF, JR, AO and AM participated in the study design.AO, JLV and JR worked on data collection. JR, VA, EN, RP and JF, performed all statistical work. VA, JF and JC were major contributors in writing the manuscript. MM, DM,JJ, JP, JB and AM reviewed and corrected the manuscript. BV contributed to prepare the manuscript according to the journal policies.